Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacGregor, D. A.
Right arrow Articles by Royster, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacGregor, D. A.
Right arrow Articles by Royster, R. L.
(Chest. 1996;109:194-200.)
© 1996 American College of Chest Physicians

Relative Efficacy and Potency of β-Adrenoceptor Agonists for Generating cAMP in Human Lymphocytes

Drew A. MacGregor MD1; Richard C. Prielipp MD1; John F. Butterworth IV MD1; Robert L. James MS1; and Roger L. Royster MD1

1 From the Departments of Anesthesia (Sections on Critical Care and Cardiac Anesthesia) and Medicine (Pulmonary/Critical Care), The Bowman Gray School of Medicine, Winston-Salem, NC.

Background: Dopexamine and dobutamine are traditionally described as having primarily β2-adrenergic agonist properties; norepinephrine is generally classified as β1-selective; and epinephrine, isoproterenol, and dopamine are considered mixed β1- and β2-receptor agonists. Much of this selectivity is designated from studies conducted with intact cardiovascular systems in which indirect actions (eg, norepinephrine release from presynaptic nerve terminals) are not separated from direct agonist-receptor interactions.

Objective: To assess the relative efficacy and potency of dopamine, dobutamine, dopexamine, epinephrine, isoproterenol, and norepinephrine for directly stimulating cyclic adenosine monophosphate (cAMP) production in human lymphocytes, a model of β2-adrenoceptor function.

Design: Open-label, prospective paired studies of lymphocytes from nine healthy human volunteers (seven men).

Setting: Experimental laboratory of a large, university-affiliated medical center.

Interventions: Concentration-response curves were generated for each adrenergic agonist; maximal cAMP production was used to compare efficacy. For the agonists that more than doubled basal cAMP concentrations, EC50 calculations were used to compare potency.

Measurements and main results: Isoproterenol and epinephrine produced the greatest concentrations of cAMP of the agonists tested. cAMP production was increased by isoproterenol at concentrations 1/10 to 1/10,000 that of the other agonists. Norepinephrine stimulated cAMP production only one third as much as epinephrine and isoproterenol, but more than double the level of dopamine, dobutamine, and dopexamine. EC50 concentrations for norepinephrine were 10-fold higher than epinephrine and 50-fold higher than isoproterenol.

Conclusions: Epinephrine and isoproterenol are the most efficacious and potent direct-acting β2adrenergic receptor agonists using this lymphocyte cAMP model. Norepinephrine exhibits significant effects on the β-receptors on lymphocytes, suggesting β2-adrenoceptor effects with high concentrations of this drug. The very low cAMP levels generated by dopamine, dobutamine, and dopexamine (even in high concentrations) support other evidence that these agents have little direct effect on the β2-adrenoceptor.

Key Words: β-adrenergic agonists • dobutamine • dopexamine • epinephrine • inotropes • isoproterenol • lymphocytes

Submitted on April 10, 1995
Accepted on August 30, 2007




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
K. TRäGER, P. RADERMACHER, K. M. RIEGER, A. VLATTEN, J. VOGT, T. IBER, J. ADLER, U. WACHTER, R. GROVER, and M. GEORGIEFF
Norepinephrine and Nomega -Monomethyl-L-arginine in Porcine Septic Shock . Effects on Hepatic O2 Exchange and Energy Balance
Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1758 - 1765.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Chest Physicians.